ReviewImmunological reviews2026
The Influenza-Specific Immunoglobulin Repertoire - Nimble Yet Steeped in Tradition.
Review in Immunological reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Influenza virus has circulated in the human population and co-evolved with us for centuries or longer, shaping our immune repertoires through a continuous host-virus arms race. Across individuals, antibodies repeatedly converge on shared solutions for capturing this shape-shifting virus by precisely targeting conserved sites of vulnerability-sites the virus cannot alter without functional cost-through structural features encoded directly by germline immunoglobulin genes. These recurring public antibodies, termed multi-donor class antibodies, have been pivotal for understanding human anti-influenza immunity and in guiding vaccine strategies that may shift the balance of the host-virus arms race. As single-cell biology, structural biology, and computational approaches mature, previously uncharted areas of our immune repertoires are coming into view. Here, we review the current understanding of the influenza-specific immune repertoire, focusing on antibodies and multi-donor antibody classes directed toward antigenic supersites on viral hemagglutinin and neuraminidase-the two major targets of protective antibodies-and discuss how these insights may advance the development of game-changing influenza vaccines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.